PSGL-1: A New Player in the Immune Checkpoint Landscape

被引:102
|
作者
Tinoco, Roberto [1 ,2 ,3 ]
Otero, Dennis C. [1 ,2 ]
Takahashi, Amy A. [1 ,2 ]
Bradley, Linda M. [1 ,2 ]
机构
[1] Sanford Burnham Prebys Med Discovery Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA
[2] Sanford Burnham Prebys Med Discovery Res Inst, Natl Canc Inst NCI Designated Canc Ctr, La Jolla, CA 92037 USA
[3] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
SELECTIN GLYCOPROTEIN LIGAND-1; CD8(+) T-CELLS; P-SELECTIN; LEUKOCYTE ADHESION; FOLLICULAR HELPER; DIFFERENTIAL EXPRESSION; SPECIALIZED FORM; BONE-MARROW; IN-VIVO; RECRUITMENT;
D O I
10.1016/j.it.2017.02.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P-selectin glycoprotein ligand-1 (PSGL-1) has long been studied as an adhesion molecule involved in immune cell trafficking and is recognized as a regulator of many facets of immune responses by myeloid cells. PSGL-1 also regulates T cell migration during homeostasis and inflammatory settings. However, recent findings indicate that PSGL-1 can also negatively regulate T cell function. Because T cell differentiation is finely tuned by multiple positive and negative regulatory signals that appropriately scale the magnitude of the immune response, PSGL-1 has emerged as an important checkpoint during this process. We summarize what is known regarding PSGL-1 structure and function and highlight how it may act as an immune checkpoint inhibitor in T cells.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 50 条
  • [31] PSGL-1 function in immunity and steady state homeostasis
    Carlow, Douglas A.
    Gossens, Klaus
    Naus, Silvia
    Veerman, Krystle M.
    Seo, Wooseok
    Ziltener, Hermann J.
    IMMUNOLOGICAL REVIEWS, 2009, 230 : 75 - 96
  • [32] VISTA is an acidic pH-selective ligand for PSGL-1
    Robert J. Johnston
    Linhui Julie Su
    Jason Pinckney
    David Critton
    Eric Boyer
    Arathi Krishnakumar
    Martin Corbett
    Andrew L. Rankin
    Rose Dibella
    Lynne Campbell
    Gaelle H. Martin
    Hadia Lemar
    Thomas Cayton
    Richard Y.-C. Huang
    Xiaodi Deng
    Akbar Nayeem
    Haibin Chen
    Burce Ergel
    Joseph M. Rizzo
    Aaron P. Yamniuk
    Sanjib Dutta
    Justine Ngo
    Andrea Olga Shorts
    Radha Ramakrishnan
    Alexander Kozhich
    Jim Holloway
    Hua Fang
    Ying-Kai Wang
    Zheng Yang
    Kader Thiam
    Ginger Rakestraw
    Arvind Rajpal
    Paul Sheppard
    Michael Quigley
    Keith S. Bahjat
    Alan J. Korman
    Nature, 2019, 574 : 565 - 570
  • [33] The adhesion mediated by the P-selectin P-selectin glycoprotein ligand-1 (PSGL-1) couple is stronger for shorter PSGL-1 variants
    Barbaux, Sandrine
    Poirier, Odette
    Pincet, Frederic
    Hermand, Patricia
    Tiret, Laurence
    Deterre, Philippe
    JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 87 (04) : 727 - 734
  • [34] PSGL-1 is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling:: In vivo studies of the PSGL-1 deficient mouse.
    Croce, K
    Merrill-Skoloff, G
    Hirata, T
    Yang, J
    Furie, BC
    Furie, B
    BLOOD, 1999, 94 (10) : 585A - 585A
  • [35] Rewiring CD8+T cell responses to PD-1 immune checkpoint blockade in PDAC by preventing terminal exhaustion via the inhibitory receptor PSGL-1
    Hope, Jennifer L.
    Zhang, Yijuan
    Hetrick, Hannah A.
    Romano, Gabriele
    Roy, Sreeja
    Lin, Michelle
    Palete, Ashley B.
    Maganti, Swetha
    Otero, Dennis C.
    Commisso, Cosimo
    Bradley, Linda M.
    CANCER RESEARCH, 2024, 84 (06)
  • [36] Regulation of CD4 cell memory by PSGL-1
    Lin, Melissa Michelle
    Bradley, Linda M.
    FASEB JOURNAL, 2008, 22
  • [37] Function of O-Glycans in Leukocyte Rolling on PSGL-1
    Whitaker, Caroline
    Ader, David
    Lawrence, Michael
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 462A - 462A
  • [38] Mechanical properties of the P-selectin/PSGL-1 interaction
    Marshall, BT
    McEver, RP
    Zhu, C
    SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW TECHNOLOGIES, 2002, : 337 - 338
  • [39] Chidamide functions as a VISTA/PSGL-1 blocker for cancer immunotherapy
    Niu, Xiaoshuang
    Zhao, Wenshan
    Zhou, Xiuman
    Luo, Feiyu
    Xiao, Youmei
    Luo, Tao
    Sui, Xinghua
    Li, Wanqiong
    Dong, Qingyu
    Yang, Xin
    He, Zhuoying
    Shang, Wenzhi
    Sun, Yixuan
    Gao, Yanfeng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (03)
  • [40] Chemoenzymatic synthesis of a tyrosine sulfated PSGL-1 glycopeptide.
    Koeller, KM
    Smith, MEB
    Wong, CH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U89 - U89